I’m not going to pretend I understood any of this for the first six months. The biology side of things has never been my strongest. I was a literature major. I am still, in many ways, a literature major.
But the thing I kept hearing about — that there was a newer approach that involved not one but two of these signaling hormones working together — eventually got my attention.
I’m going to do my best in this article to explain what I learned, in the language of a regular woman with a kitchen table and a notebook, not in the language of a clinical trial. If you’re considering GLP-1 and you’re confused by the fact that there now seem to be multiple categories of GLP-1, this is the article I wish someone had written for me when I was confused about it too.
I thought one hormone was already kind of impressive
The whole concept of using a copy of a hormone the body already makes, to support a thing the body was supposed to be doing on its own — that already seemed wild to me when I first heard it.
The idea that there could be a version that did that with two complementary signals at the same time was almost too much for my literature-major brain. I had to read about it three times. I made my husband listen to me explain it. He pretended he understood.
The original generation of GLP-1 medications worked on one hormone — the one called GLP-1, which is where the whole category gets its name. The newer generation works on GLP-1 and also on a second hormone called GIP. Both of these hormones, on their own, do similar but slightly different jobs in how your body responds to food. Together, they apparently do more than either does alone. Which makes intuitive sense the more you sit with it.
Fat tissue is more interesting than I knew
Here’s the part I didn’t expect. I had always thought of fat as a problem. A storage problem. A passive problem. Something to get rid of.
What I’ve been learning is that fat tissue is actually doing things. It’s involved in signaling. It’s involved in hormones. It’s involved in how your body talks to itself. Helping it be a healthier kind of tissue, instead of just trying to delete it, is a different posture toward your own body. I’m still adjusting to it.
The dual-hormone GLP-1 medications, from what I’ve read, work on fat tissue specifically in ways the single-hormone versions don’t. They don’t just reduce the amount of it. They change the function of it. Which means the body that’s left at the end of the process is, on average, a healthier body, not just a smaller one. That’s a category difference I find genuinely meaningful.
The numbers people are comparing are not small
I won’t quote specifics because I don’t have them in front of me, and also because every person’s situation is its own situation. But the general thing I keep hearing — that combining two of these signals gets you a different category of result than just one — has held up in the conversations I’ve been part of.
Which is interesting because, in a lot of medicine, the older simpler version usually does most of the work and the newer thing is marginal. This is one of the few places where the newer thing seems, by the accounts I’ve heard, to be a real step up.
My doctor was the one who walked me through this. She showed me the comparative numbers in language I could follow. The gap between the single-hormone results and the dual-hormone results, on average, was bigger than I expected. Not subtle. Significant. Which is part of why my doctor and I, after a long conversation, landed on the dual-hormone version for my situation.
I’m not a doctor and I’m not pretending to be
I want to be honest about my level here. I am a curious person with a kitchen island and a notebook. I read things. I ask questions. I have opinions that are constantly being updated by people who know more than me.
If you want the actual science, the actual science is out there and a lot of it is written for regular humans these days. Look it up. Ask a real professional. Don’t take a literature major’s word for it.
What I will say, having now been on the dual-hormone GLP-1 for several months, is that the difference matches the description. Hunger is quieter. Fullness arrives sooner and stays longer. Energy is more consistent. None of these are claims I’d put in a medical journal. All of these are observations from my own kitchen. Take them for what they’re worth.
What I’ll say is the conversation has expanded
The category of available options is wider than it used to be. The conversations my friends and I are having about our bodies are wider than they used to be. The questions we’re asking our doctors are wider than they used to be.
That’s the part I find most genuinely exciting. Not any one specific thing. Just the fact that for the first time in a long time, there’s actually more than one direction to go.
If you’re starting GLP-1 or thinking about it, please know that ‘GLP-1’ is not a single thing. It’s a category with branches. The original branch is one thing. The dual-hormone branch is something different. The oral options are different again. Ask your doctor which branch is right for your specific situation and your specific goals. The answer isn’t the same for everyone. The fact that there are now multiple right answers, for different women, is itself a pretty remarkable thing.
